First Randomized Trial of IVIG for Autoimmune POTS Finds No Significant Effect : Neurology Today
An abstract is unavailable.
An abstract is unavailable.
For the month of May, the eanCampus is highlighting the topic of headache, with several pieces of content freely accessible for you to enjoy.
Background and ObjectivesSerum neurofilament light chain (sNfL) levels correlate with multiple sclerosis (MS) disease activity, but the dynamics of this correlation are unknown. We evaluated…
Fracture detection is one of the most commonly used and studied aspects of artificial intelligence (AI) in medicine. In this systematic review and meta-analysis, we…
Background and ObjectivesThere is a paucity of high-level evidence for endovascular thrombectomy (EVT) in posterior cerebral artery (PCA) strokes.MethodsThe MEDLINE, Embase, and Web of Science…
Sentara Health, an Award Winning, Innovative, Non-Profit, Healthcare System in Beautiful Virginia, is expanding their neurology divisions.
This secondary analysis of a randomized clinical trial examines whether warning letters to high prescribers of quetiapine are associated with reduced prescribing to patients with…
Background and ObjectivesPopulation-based studies on stroke can help guide the care of patients with acute ischemic stroke (AIS) by providing health care communities with information…
This randomized clinical trial investigates the effects of solanezumab and ganterenumab on downstream biomarkers in individuals with dominantly inherited Alzheimer disease.
Recent scientific advancements in the field of Alzheimer disease (AD) have led to numerous questions and challenges. On the one hand, with the emergence of…
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care